Dementia Australia welcomes UK approval of lecanemab to tackle Alzheimer’s – Diabetes Prevention Awareness Center

Dementia Australia welcomes UK approval of lecanemab to tackle Alzheimer’s

Post author:
Post published:August 27, 2024
Post category:uncategorized
Post comments:0 Comments

Dementia Australia welcomes the decision by the Medicines and Healthcare Products Regulatory Agency to approve Lecanemab for use in the UK.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

© 2024 Diabetes Prevention Awareness Center.